rimantadine hydrochloride has been researched along with amantadine in 5 studies
*Amantadine: An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. [MeSH]
*Amantadine: An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anfimov, PM; Beklemishev, AB; Kiselev, OI; Lavrinenko, VA; Pokrovsky, CA; Pokrovsky, CE; Salakhutdinov, NF; Shernyukov, CA; Sokolova, AS; Tretiak, TS; Yarovaya, CO; Zarubaev, VV | 1 |
| Anfimov, PM; Kiselev, OI; Korchagina, DV; Salakhutdinov, NF; Sokolova, AS; Tretiak, TS; Yarovaya, OC; Zarubaev, VV | 1 |
| Barniol-Xicota, M; DeGrado, WF; Frigolé-Vivas, M; Juárez-Jiménez, J; Lamb, RA; Llabrés, S; Luque, FJ; Ma, C; Naesens, L; Pinto, LH; Rey-Carrizo, M; Torres, E; Vázquez, S | 1 |
| Baev, DS; Salakhutdinov, NF; Shernyukov, АV; Shtro, AA; Sokolova, AS; Yarovaya, ОI; Zarubaev, VV | 1 |
| Barbier, J; Cintrat, JC; Davey, RA; Gillet, D; Kali, S; Noël, R; Pons, V; Popoff, MR; Shtanko, O; Tordo, N; Wu, Y | 1 |
5 other study(ies) available for rimantadine hydrochloride and amantadine
| Article | Year |
|---|---|
New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity.
Topics: Animals; Antiviral Agents; Binding Sites; Bridged Bicyclo Compounds; Camphor; Cell Line, Tumor; Cell Survival; Dogs; Escherichia coli; Humans; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Molecular Docking Simulation; Mutagenicity Tests; Protein Structure, Tertiary; Quaternary Ammonium Compounds; Viral Matrix Proteins | 2013 |
Camphor-based symmetric diimines as inhibitors of influenza virus reproduction.
Topics: Animals; Antiviral Agents; Camphor; Dogs; Dose-Response Relationship, Drug; Imines; Influenza A virus; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Virus Replication | 2014 |
Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus.
Topics: Amantadine; Amines; Animals; Dogs; Drug Resistance, Viral; Influenza A virus; Ion Channels; Madin Darby Canine Kidney Cells; Models, Molecular; Mutation; Orthomyxoviridae Infections; Patch-Clamp Techniques; Pyrrolidines; Structure-Activity Relationship; Viral Matrix Proteins; Xenopus | 2014 |
Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1.
Topics: Antiviral Agents; Camphor; Hemagglutinin Glycoproteins, Influenza Virus; Hydrophobic and Hydrophilic Interactions; Imines; Influenza A Virus, H1N1 Subtype; Molecular Docking Simulation; Protein Conformation; Structure-Activity Relationship | 2017 |
DABMA: A Derivative of ABMA with Improved Broad-Spectrum Inhibitory Activity of Toxins and Viruses.
Topics: | 2019 |